CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2020	Mar. 31, 2019
Current assets:
Cash and cash equivalents	$ 59,500	$ 25,704
Short-term investments	109,055	109,107
Research and development incentives receivable	2,962	2,474
Prepaid expenses and other current assets	2,734	3,696
Total current assets	174,251	140,981
Property, plant and equipment, net	6,860	12,159
Restricted cash	1,636	1,186
Right-to-use asset - operating leases	4,425
Right-to-use asset - financing leases	46,925
Total assets	234,097	154,326
Current liabilities:
Accounts payable	3,434	7,084
Accrued expenses and other current liabilities	5,156	2,801
Operating lease liabilities, current	873
Financing lease liabilities, current	2,411
Total current liabilities	11,874	9,885
Deferred rent, net of current portion		24
Financing obligation		6,561
Long term debt, net of debt discount	9,801
Operating lease liabilities, non-current	3,737
Finance lease liabilities, non-current	24,967
Total liabilities	50,379	16,470
Commitments and contingencies (Note 12)
Stockholders' Equity:
Common stock, $0.001 par value; 150,000,000 shares authorized as of March 31, 2020 and 2019: 36,668,743 and 31,656,950 shares issued and outstanding as of March 31, 2020 and 2019, respectively	37	32
Additional paid-in capital	296,961	198,645
Accumulated deficit	(112,298)	(59,766)
Accumulated other comprehensive loss	(982)	(1,055)
Total stockholders' equity	183,718	137,856
Total liabilities and stockholders' equity	$ 234,097	$ 154,326